Dextrose Electrolyte No. 75 and Lyme disease vaccine (recombinant ospa) Intramuscular
Determining the interaction of Dextrose Electrolyte No. 75 and Lyme disease vaccine (recombinant ospa) Intramuscular and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: lvp solution with potassium
Brand name:
Synonyms: Dextrose and Electrolyte No 48
Generic Name: lyme disease vaccine
Brand name:
Synonyms: Lyme disease vaccine (recombinant ospa)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Dextrose Electrolyte No. 75-Lymepak
- Dextrose Electrolyte No. 75-Lymphocyte immune globulin, anti-thymocyte equine
- Dextrose Electrolyte No. 75-Lymphoseek
- Dextrose Electrolyte No. 75-Lynparza
- Dextrose Electrolyte No. 75-Lynparza (Olaparib Capsules)
- Dextrose Electrolyte No. 75-Lynparza (Olaparib Tablets)
- Lyme disease vaccine (recombinant ospa) Intramuscular-Dextrose Gel and Liquid
- Lyme disease vaccine (recombinant ospa) Intramuscular-Dextrose Injection
- Lyme disease vaccine (recombinant ospa) Intramuscular-Dextrose Injection 10%
- Lyme disease vaccine (recombinant ospa) Intramuscular-Dextrose Injection 70%
- Lyme disease vaccine (recombinant ospa) Intramuscular-Dextrose Injection Concentrated
- Lyme disease vaccine (recombinant ospa) Intramuscular-Dextrose Injection Infants